Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers During the Perioperative Period: to Withdraw or to Continue? A Multicenter Randomized Controlled Trial

NCT04506372 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT04506372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04506372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers During the Perioperative Period: to Withdraw or to Continue? A Multicenter Randomized Controlled Trial
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Terminated
Start date
September 11, 2020
Completion date
September 1, 2023
Enrollment
342 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

angiotensin hypertension, perioperative complication, surgery